{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:08Z","timestamp":1759336328878},"reference-count":43,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.intimp.2005.04.001","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T11:22:13Z","timestamp":1114860133000},"page":"1317-1329","source":"Crossref","is-referenced-by-count":6,"title":["Presence of a peptide component of thymosin fraction-5 manifesting discrete cytostatic properties in HL-60 human promyelocytic leukemia cells"],"prefix":"10.1016","volume":"5","author":[{"given":"Bryan L.","family":"Spangelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Pompilius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derald D.","family":"Farrimond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Nieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Badamchian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. David","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2005.04.001_bib1","first-page":"191","article-title":"Thymosins and other hormones of the thymus gland","volume":"58","author":"Schulof","year":"1981","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.intimp.2005.04.001_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/ten.1999.5.499","article-title":"Age and disease-related decline in immune function: an opportunity for thymus-boosting therapies","volume":"5","author":"Berthiaume","year":"1999","journal-title":"Tissue Eng"},{"key":"10.1016\/j.intimp.2005.04.001_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1040-8428(85)80035-4","article-title":"Thymic peptide hormones: basic properties and clinical applications in cancer","volume":"3","author":"Schulof","year":"1985","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.intimp.2005.04.001_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1749-6632.1987.tb35766.x","article-title":"Biology and chemistry of thymosin peptides: modulators of immunity and neuroendocrine circuits","volume":"496","author":"Spangelo","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2005.04.001_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1210\/endo-128-3-1580","article-title":"Complete amino acid sequence analysis of a peptide isolated from the thymus that enhances release of growth hormone and prolactin","volume":"128","author":"Badamchian","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2005.04.001_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1470005","article-title":"Commentary: the thymic\u2013endocrine connection","volume":"147","author":"Spangelo","year":"1995","journal-title":"J Endocrinol"},{"key":"10.1016\/j.intimp.2005.04.001_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1975.tb29063.x","article-title":"Purification and properties of bovine thymosin","volume":"249","author":"Hooper","year":"1975","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2005.04.001_bib8","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1210\/en.139.4.2155","article-title":"Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro","volume":"139","author":"Spangelo","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2005.04.001_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1749-6632.2000.tb05425.x","article-title":"Interleukin-1\u03b2 and thymic peptide regulation of pituitary and glial cell cytokine expression and cellular proliferation","volume":"917","author":"Spangelo","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2005.04.001_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjc.1973.150","article-title":"Immunotherapy of the Dunning leukemia with thymic extracts","volume":"28","author":"Khaw","year":"1973","journal-title":"Br J Cancer"},{"key":"10.1016\/j.intimp.2005.04.001_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0008-8749(76)90121-0","article-title":"Augmentation of specific macrophage-mediated cytotoxicity: correlation with agents which enhance antitumor resistance","volume":"25","author":"Schultz","year":"1976","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2005.04.001_bib12","first-page":"2139","article-title":"Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB\/c mice treated in vivo with thymosin fraction V","volume":"42","author":"Petro","year":"1982","journal-title":"Can Res"},{"key":"10.1016\/j.intimp.2005.04.001_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0145-2126(83)90072-3","article-title":"Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3)","volume":"7","author":"Ho","year":"1983","journal-title":"Leuk Res"},{"key":"10.1016\/j.intimp.2005.04.001_bib14","first-page":"471","article-title":"Biochemical and immunological differentiation of human thymocytes induced by thymic hormones","volume":"50","author":"Ho","year":"1983","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2005.04.001_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V54.3.713.713","article-title":"Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia","volume":"54","author":"Gallagher","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2005.04.001_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.2910170504","article-title":"Establishment and characterization of a human histiocytic lymphoma cell line (U937)","volume":"17","author":"Sundstrom","year":"1976","journal-title":"Int J Cancer"},{"key":"10.1016\/j.intimp.2005.04.001_bib17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/mol.52.6.935","article-title":"Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine","volume":"52","author":"Jarvis","year":"1997","journal-title":"Mol Pharm"},{"key":"10.1016\/j.intimp.2005.04.001_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1976.tb41733.x","article-title":"In vitro and in vivo studies with thymosin in cancer patients","volume":"277","author":"Schafer","year":"1976","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2005.04.001_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V58.2.285.285","article-title":"Clonal analysis of the response of human myeloid leukemic cell lines to colony-stimulating activity","volume":"58","author":"Ruscetti","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2005.04.001_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000047824","article-title":"Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53","volume":"12","author":"Teijeiro","year":"2002","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.intimp.2005.04.001_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0196-9781(99)00037-6","article-title":"Growth inhibitory effects of somatostatin on human leukemia cell lines mediated by somatostatin receptor subtype 1","volume":"20","author":"Ishihara","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.intimp.2005.04.001_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0162-3109(86)90007-X","article-title":"Suppressive effect of thymosin fraction 5 on proliferation of cultured human T-lymphocytes","volume":"2","author":"Wolf","year":"1986","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.intimp.2005.04.001_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(99)00238-4","article-title":"Augmentation of antitumor activity of 5\u2032-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells both in vitro and in vivo","volume":"145","author":"Ikemoto","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2005.04.001_bib24","first-page":"167","article-title":"Thymosin beta-10 accelerates apoptosis","volume":"41","author":"Hall","year":"1995","journal-title":"Cell Mol Biol Res"},{"key":"10.1016\/j.intimp.2005.04.001_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0047-6374(96)01860-X","article-title":"Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+CD8+ thymocytes through the activation of cAMP- and PKC-dependent second messenger pathways","volume":"94","author":"Baumann","year":"1997","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.intimp.2005.04.001_bib26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0192-0561(00)00065-5","article-title":"Thymosin \u03b11 is a time and dose-dependent antagonist of dexamethasone-induced apoptosis of murine thymocytes in vitro","volume":"22","author":"Baumann","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.intimp.2005.04.001_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0006-2952(99)00030-1","article-title":"Decreased thymosin \u03b24 in apoptosis induced by a variety of antitumor drugs","volume":"57","author":"Iguchi","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.intimp.2005.04.001_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/15419060009015002","article-title":"Increased resistance to apoptosis in cells overexpressing thymosin \u03b2-four: a role for focal adhesion kinase pp125FAK","volume":"7","author":"Niu","year":"2000","journal-title":"Cell Adhes Commun"},{"key":"10.1016\/j.intimp.2005.04.001_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1023\/A:1024938325032","article-title":"Reduction of thymosin \u03b24 and actin in HL-60 cells during apoptosis is preceded by a decrease of their mRNAs","volume":"250","author":"Muller","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.intimp.2005.04.001_bib30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1167\/iovs.03-1002","article-title":"Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro","volume":"45","author":"Sosne","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.intimp.2005.04.001_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1749-6632.1975.tb29064.x","article-title":"Thymosin-induced differentiation of murine thymocytes in allogeneic mixed lymphocyte cultures","volume":"249","author":"Cohen","year":"1975","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.intimp.2005.04.001_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0008-8749(83)90288-5","article-title":"Changes in purine nucleoside phosphorylase activity during thymosin-induced human null cell differentiation","volume":"78","author":"Cowan","year":"1983","journal-title":"Cell Immunol"},{"issue":"Pt. B","key":"10.1016\/j.intimp.2005.04.001_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4757-0390-0_20","article-title":"Changes in purine salvage pathway enzyme activities during human lymphocyte differentiation induced by thymosin fraction 5","volume":"165","author":"Cowan","year":"1984","journal-title":"Adv Exp Med"},{"key":"10.1016\/j.intimp.2005.04.001_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-3083.1985.tb01424.x","article-title":"Terminal differentiation of cord blood lymphocytes induced by thymosin fraction 5 and thymosin \u03b11","volume":"21","author":"Ho","year":"1985","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.intimp.2005.04.001_bib35","first-page":"77","article-title":"Differentiation changes in cord blood T lymphocytes induced by synthetic C-terminal peptides of thymosin \u03b11","volume":"9","author":"Ho","year":"1987","journal-title":"Thymus"},{"key":"10.1016\/j.intimp.2005.04.001_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0090-1229(78)90137-X","article-title":"The in vitro induction of differentiation of putative human stem cells by thymosin and agents that affect cyclic AMP","volume":"9","author":"Horowitz","year":"1978","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.intimp.2005.04.001_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0192-0561(99)00087-9","article-title":"Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin \u03b11","volume":"22","author":"Roy","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.intimp.2005.04.001_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature03000","article-title":"Thymosin \u03b24 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair","volume":"432","author":"Bock-Marquette","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2005.04.001_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.4.4.559","article-title":"Thymosins: chemistry and biological properties in health and disease","volume":"4","author":"Goldstein","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.intimp.2005.04.001_bib40","first-page":"151","article-title":"Phase II trial of thymosin fraction 5 in advanced renal cancer","volume":"3","author":"Schulof","year":"1984","journal-title":"J Biol Response Modif"},{"key":"10.1016\/j.intimp.2005.04.001_bib41","first-page":"137","article-title":"Phase II study of thymosin fraction 5 in the treatment of metastatic renal cell carcinoma","volume":"69","author":"Dimitrov","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.intimp.2005.04.001_bib42","first-page":"1663","article-title":"Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer","volume":"48","author":"Scher","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2005.04.001_bib43","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1210\/en.2004-0246","article-title":"Tumor necrosis factor \u03b1 inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation","volume":"145","author":"Shen","year":"2004","journal-title":"Endocrinology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T05:01:29Z","timestamp":1586235689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576905001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":43,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1567576905001001"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2005.04.001","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}